121 related articles for article (PubMed ID: 3320345)
1. Activation of serotonin2 (5-HT2) receptors by quipazine increases arterial pressure and renin secretion in conscious rats.
Alper RH; Snider JM
J Pharmacol Exp Ther; 1987 Dec; 243(3):829-33. PubMed ID: 3320345
[TBL] [Abstract][Full Text] [Related]
2. Quipazine increases renin release by a peripheral hemodynamic mechanism.
Zink MH; Pergola PE; Doane JF; Sved AF; Alper RH
J Cardiovasc Pharmacol; 1990 Jan; 15(1):1-9. PubMed ID: 1688963
[TBL] [Abstract][Full Text] [Related]
3. LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat.
Cohen ML; Fuller RW; Kurz KD
J Pharmacol Exp Ther; 1983 Nov; 227(2):327-32. PubMed ID: 6313898
[TBL] [Abstract][Full Text] [Related]
4. Hemodynamic pharmacology of p-chloroamphetamine, a serotonin agonist, in conscious rats.
Alper RH; Lee C; Brody MJ
J Pharmacol Exp Ther; 1987 Nov; 243(2):446-54. PubMed ID: 3681694
[TBL] [Abstract][Full Text] [Related]
5. Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067.
Cohen ML; Fuller RW; Kurz KD; Parli CJ; Mason NR; Meyers DB; Smallwood JK; Toomey RE
J Pharmacol Exp Ther; 1988 Jan; 244(1):106-12. PubMed ID: 3335993
[TBL] [Abstract][Full Text] [Related]
6. Effects of quipazine on blood pressure in pithed rats.
Shin YK; Svinareff P; Schmitt-Jubeau H; Schmitt H
Arch Int Pharmacodyn Ther; 1983 Jul; 264(1):73-81. PubMed ID: 6138006
[TBL] [Abstract][Full Text] [Related]
7. Discriminative stimulus properties of quipazine: mediation by serotonin2 binding sites.
Friedman RL; Barrett RJ; Sanders-Bush E
J Pharmacol Exp Ther; 1984 Mar; 228(3):628-35. PubMed ID: 6707913
[TBL] [Abstract][Full Text] [Related]
8. An effect of extrarenal beta adrenergic stimulation on the release of renin.
Reid IA; Schrier RW; Earley LE
J Clin Invest; 1972 Jul; 51(7):1861-9. PubMed ID: 4402350
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of centrally administered arachidonic acid in haemorrhage-induced hypotensive rats: investigation of a peripheral mechanism.
Yalcin M; Aydin C
Clin Exp Pharmacol Physiol; 2009 Apr; 36(4):447-53. PubMed ID: 19702598
[TBL] [Abstract][Full Text] [Related]
10. Effect of clonidine, quipazine, and LY 53857 on the prolactin-suppressant action of bromocriptine in rats.
Lipham LB; Booth NH; Jernigan AD; Robbins JD; Hatch RC
Am J Vet Res; 1986 May; 47(5):1089-91. PubMed ID: 3717731
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological analysis of the haemodynamic effects of 5-HT1B/D receptor agonists in the normotensive rat.
Pagniez F; Valentin JP; Vieu S; Colpaert FC; John GW
Br J Pharmacol; 1998 Jan; 123(2):205-14. PubMed ID: 9489607
[TBL] [Abstract][Full Text] [Related]
12. Noradrenergic denervation alters serotonin2-mediated behavior but not serotonin2 receptor number in rats: modulatory role of beta adrenergic receptors.
Eison AS; Yocca FD; Gianutsos G
J Pharmacol Exp Ther; 1988 Aug; 246(2):571-7. PubMed ID: 2900327
[TBL] [Abstract][Full Text] [Related]
13. [Activation of the renin-angiotensin system and blood pressure variability in rats].
Blanc J; Lambert G; Elghozi JL
Arch Mal Coeur Vaiss; 2000 Aug; 93(8):1019-22. PubMed ID: 10989749
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of centrally injected melittin in hemorrhaged hypotensive rats: the investigation of peripheral mechanisms.
Yalcin M; Savci V
Neuropeptides; 2007 Dec; 41(6):465-75. PubMed ID: 17897713
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological, hemodynamic and autonomic nervous system mechanisms responsible for the blood pressure and heart rate lowering effects of pergolide in rats.
Cavero I; Lefevre-Borg F; Lhoste F; Sabatier C; Richer C; Giudicelli JF
J Pharmacol Exp Ther; 1984 Mar; 228(3):779-91. PubMed ID: 6707926
[TBL] [Abstract][Full Text] [Related]
16. Intrarenal infusion of bradykinin elicits a pressor response in conscious rats via a B2-receptor mechanism.
Hoagland KM; Maddox DA; Martin DS
Can J Physiol Pharmacol; 1999 Aug; 77(8):563-70. PubMed ID: 10543719
[TBL] [Abstract][Full Text] [Related]
17. Evidence that the serotonin agonist, DOI, increases renin secretion and blood pressure through both central and peripheral 5-HT2 receptors.
Rittenhouse PA; Bakkum EA; Van de Kar LD
J Pharmacol Exp Ther; 1991 Oct; 259(1):58-65. PubMed ID: 1920135
[TBL] [Abstract][Full Text] [Related]
18. Hemodynamic and renin responses to (+-)-DOI, a selective 5-HT2 receptor agonist, in conscious rats.
Alper RH
Eur J Pharmacol; 1990 Jan; 175(3):323-32. PubMed ID: 2182326
[TBL] [Abstract][Full Text] [Related]
19. Evidence for central and peripheral serotonergic control of corticosterone secretion in the conscious rat.
Alper RH
Neuroendocrinology; 1990 Mar; 51(3):255-60. PubMed ID: 2109269
[TBL] [Abstract][Full Text] [Related]
20. The cardiovascular effects of quipazine are mediated by peripheral 5-HT2 and 5-HT3 receptors in anaesthetized rats.
Vayssettes-Courchay C; Bouysset F; Verbeuren TJ; Laubie M; Schmitt H
Eur J Pharmacol; 1990 Aug; 184(1):75-85. PubMed ID: 2120077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
